TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion
Clinical trial NCT07075562 · COMPLETED
Trial details
- NCT number
- NCT07075562
- Sponsor
- The First Hospital of Hebei Medical University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2024-03-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.